Insiders / Gadicke Ansbert
Gadicke Ansbert
CIK 1134655personinsider
Companies
1
First seen
Jan 8, 2026
Last activity
Jan 14, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Aktis Oncology, Inc. · AKTS | 10,260,064 | — |
All securities held
1 position · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Aktis Oncology, Inc. | Common Stock | 10,260,064 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Buy | AKTS Aktis Oncology, Inc. Common Stock | $20.03M | +1.1M +12.17% | 10,260,064 18.56% of shares | high |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Series B Redeemable Convertible Preferred Stock | — | -6.0M -100.00% | 0 0.00% of shares | low |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Series A Redeemable Convertible Preferred Stock | — | -22.5M -100.00% | 0 0.00% of shares | low |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Series Seed Redeemable Convertible Preferred Stock | — | -5.0M -100.00% | 0 0.00% of shares | low |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Common Stock | — | +1.6M +20.83% | 9,147,287 16.55% of shares | low |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Common Stock | — | +5.9M +357.14% | 7,570,168 13.69% of shares | low |
| Jan 12, 2026 | Other | AKTS Aktis Oncology, Inc. Common Stock | — | +1.3M +384.61% | 1,655,971 3.00% of shares | low |